DIFFERENTIAL DIAGNOSIS BETWEEN HYPOTHALAMIC AND PITUITARY hGH DEFICIENCY WITH THE AID OF SYNTHETIC GH‐RH 1–44
- 1 July 1984
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 21 (1) , 9-12
- https://doi.org/10.1111/j.1365-2265.1984.tb00130.x
Abstract
Synthetic GH‐RH 1–44 administered as an intravenous bolus (1 μg/kg) evoked a marked hGH rise (>20 ng/ml) in three children with constitutional short stature and in two of eight children diagnosed as having hGH deficiency by insulin hypoglycaemia and/or clonidine tests. As judged by the intensity of the hGH response to the dose employed and the peak time, GH‐RH 1–44 may be as potent as GH‐RH 1–40 in children. It is concluded that GH‐RH is an important addition to the endocrine armamentarium, providing the means for differentiation between hypothalamic and pituiary hGH deficiency in a simple test which is devoid of side effects.This publication has 5 references indexed in Scilit:
- GROWTH-HORMONE-RELEASING FACTOR IN GROWTH HORMONE DEFICIENCY: DEMONSTRATION OF A HYPOTHALAMIC DEFECT IN GROWTH HORMONE RELEASEThe Lancet, 1983
- EFFECTS OF HUMAN PANCREATIC TUMOUR GROWTH HORMONE RELEASING FACTOR ON GROWTH HORMONE AND SOMATOMEDIN C LEVELS IN PATIENTS WITH IDIOPATHIC GROWTH HORMONE DEFICIENCYThe Lancet, 1983
- HUMAN PANCREATIC GROWTH-HORMONE-RELEASING FACTOR SELECTIVELY STIMULATES GROWTH-HORMONE SECRETION IN MANThe Lancet, 1983
- Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused AcromegalyScience, 1982
- Characterization of a growth hormone-releasing factor from a human pancreatic islet tumourNature, 1982